These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10465405)

  • 1. Design, synthesis and biological evaluation of selective boron-containing thrombin inhibitors.
    Wienand A; Ehrhardt C; Metternich R; Tapparelli C
    Bioorg Med Chem; 1999 Jul; 7(7):1295-307. PubMed ID: 10465405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
    Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP
    Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective boron-containing thrombin inhibitors--X-ray analysis reveals surprising binding mode.
    von Matt A; Ehrhardt C; Burkhard P; Metternich R; Walkinshaw M; Tapparelli C
    Bioorg Med Chem; 2000 Sep; 8(9):2291-303. PubMed ID: 11026541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyanopeptide analogues: new lead structures for the design and synthesis of new thrombin inhibitors.
    Radau G; Stürzebecher J
    Pharmazie; 2002 Nov; 57(11):729-32. PubMed ID: 12611274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly selective tripeptide thrombin inhibitors.
    Shuman RT; Rothenberger RB; Campbell CS; Smith GF; Gifford-Moore DS; Gesellchen PD
    J Med Chem; 1993 Feb; 36(3):314-9. PubMed ID: 8426361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New tripeptidic thrombin inhibitors. Influence of P2 and P3 residues on activity and selectivity.
    De Nanteuil G; Gloanec P; Lila C; Portevin B; Boudon A; Rupin A; Verbeuren TJ
    Bioorg Med Chem; 1995 Aug; 3(8):1019-24. PubMed ID: 7582976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors.
    Wagner J; Kallen J; Ehrhardt C; Evenou JP; Wagner D
    J Med Chem; 1998 Sep; 41(19):3664-74. PubMed ID: 9733491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease inhibitors: synthesis and QSAR study of novel classes of nonbasic thrombin inhibitors incorporating sulfonylguanidine and O-methylsulfonylisourea moieties at P1.
    Supuran CT; Scozzafava A; Briganti F; Clare BW
    J Med Chem; 2000 May; 43(9):1793-806. PubMed ID: 10794696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Episelection: novel Ki approximately nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface.
    Katz BA; Finer-Moore J; Mortezaei R; Rich DH; Stroud RM
    Biochemistry; 1995 Jul; 34(26):8264-80. PubMed ID: 7599119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
    Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
    Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent thrombin inhibitors that probe the S1 subsite: tripeptide transition state analogues based on a heterocycle-activated carbonyl group.
    Costanzo MJ; Maryanoff BE; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Kauffman JA; Lewis JM; Krishnan R; Tulinsky A
    J Med Chem; 1996 Aug; 39(16):3039-43. PubMed ID: 8759623
    [No Abstract]   [Full Text] [Related]  

  • 13. Azetidin-2-one derivatives as inhibitors of thrombin.
    Han WT; Trehan AK; Wright JJ; Federici ME; Seiler SM; Meanwell NA
    Bioorg Med Chem; 1995 Aug; 3(8):1123-43. PubMed ID: 7582985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
    Bhunia SS; Roy KK; Saxena AK
    J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.
    Ganesh V; Lee AY; Clardy J; Tulinsky A
    Protein Sci; 1996 May; 5(5):825-35. PubMed ID: 8732754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retro-binding thrombin active site inhibitors: identification of an orally active inhibitor of thrombin catalytic activity.
    Iwanowicz EJ; Kimball SD; Lin J; Lau W; Han WC; Wang TC; Roberts DG; Schumacher WA; Ogletree ML; Seiler SM
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3183-6. PubMed ID: 12372529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting subsite interactions of plasmin with substrates and inhibitors through computational docking analysis.
    Gohda K; Teno N; Wanaka K; Tsuda Y
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):571-7. PubMed ID: 21992704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tripeptides with non-code amino acids as potential serine proteases inhibitors.
    Markowska A; Bruzgo M; Surażyński A; Midura-Nowaczek K
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):639-43. PubMed ID: 22299583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 position.
    Baettig U; Brown L; Brundish D; Dell C; Furzer A; Garman S; Janus D; Kane PD; Smith G; Walker CV; Cockcroft X; Ambler J; Mitchelson A; Talbot MD; Tweed M; Wills N
    Bioorg Med Chem Lett; 2000 Jul; 10(14):1563-6. PubMed ID: 10915051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase.
    Jackson DS; Fraser SA; Ni LM; Kam CM; Winkler U; Johnson DA; Froelich CJ; Hudig D; Powers JC
    J Med Chem; 1998 Jun; 41(13):2289-301. PubMed ID: 9632362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.